Franchise opportunities compared
MN Filing 35653-202603-10 vs NexGenEsis Healthcare
Reviewed figures from each brand's Franchise Disclosure Document (FDD), side by side. Each figure carries its FDD year and page. This is not a ranking or recommendation, and the two FDDs may cover different years and location groups.
Before you compare
- MN Filing 35653-202603-10 figures come from its 2026 FDD and NexGenEsis Healthcare figures from its 2025 FDD, so the years differ.
- MN Filing 35653-202603-10 discloses more than one business format, so the investment range spans formats; the full report breaks them out.
- Item 19 figures cover the location groups each FDD names (MN Filing 35653-202603-10: 24, NexGenEsis Healthcare: 2). Different groups are not directly comparable.
| Disclosure | MFMN Filing 35653-202603-10 |  NexGenEsis Healthcare |
|---|---|---|
| Financial commitment | ||
| Estimated initial investment (Item 7) | $73,523 – $1,228,956 2026 FDD · Item 7 | Not available No reviewed Item 7 total |
| Standard initial franchise fee (Item 5) | $30,000 2026 FDD · Item 5 · PDF p. 17 | Not available No single standard fee identified |
| Royalty (Item 6) | 7% Royalty, full service EyeCare Center 2026 FDD · Item 6 · PDF p. 18 | $7.00 Royalty rate 2025 FDD · Item 6 · PDF p. 19 |
| Brand / advertising fund (Item 6) | 8% Advertising contribution — 8% 2026 FDD · Item 6 · PDF p. 18 | $1.00 Brand Fund annual increase cap 2025 FDD · Item 6 · PDF p. 19 |
| System scale & health | ||
| Total outlets (Item 20) | 484 Outlets at end of 2025 2026 FDD · Item 20 · PDF p. 82 | Not available No reviewed outlet counts |
| Net outlet change (Item 20) | −22 Calculated: 506 at end of 2023 → 484 at end of 2025 | Not available Only one year reported |
| Outlet exits (Item 20) | Not available No complete exit records for a year | Not available No complete exit records for a year |
| Franchising since (Item 1) | Not available Not in reviewed records | Not available Not in reviewed records |
| Franchisor founded (Item 1) | Not available Not in reviewed records | Not available Not in reviewed records |
| Performance (Item 19) | ||
| Financial performance (Item 19), by location group | Locations counted not stated in the reviewed record — Fourth quartile of reporting OD owner EyeCare Centers using the full service op… $475 other Table 1A · 2026 FDD · Item 19 · PDF p. 75 Locations counted not stated in the reviewed record — All reporting employed EyeCare Centers owned by an optometrist, ophthalmologist… $889 median Table 3A · 2026 FDD · Item 19 · PDF p. 79 Locations counted not stated in the reviewed record — All reporting OD owner EyeCare Centers $2,245 other Table OD owner · 2026 FDD · Item 19 · PDF p. 76 +21 more groups in the full report | Franchised (1 locations) — EBITDA and costs and other measures and revenue and profit -$64,254.00 other Adjusted EBITDA · 2025 FDD · Item 19 · PDF p. 63 Locations counted not stated in the reviewed record 3 locations other Affiliate Reporting Group reporting locations · 2025 FDD · Item 19 · PDF p. 61 |
Item 19 groups are shown separately and never combined. Revenue or sales figures are not profit. Net outlet change and turnover are Franopolis calculations from the disclosed counts; turnover is a count-based rate, not a measure of owner earnings.
MN Filing 35653-202603-10 vs NexGenEsis Healthcare: common questions
- How do MN Filing 35653-202603-10 and NexGenEsis Healthcare royalties compare?
- MN Filing 35653-202603-10: 7% (2026 FDD · Item 6 · PDF p. 18); NexGenEsis Healthcare: $7.00 (2025 FDD · Item 6 · PDF p. 19). Royalties as disclosed in Item 6; other recurring fees are listed separately.
- Do MN Filing 35653-202603-10 and NexGenEsis Healthcare disclose financial performance (Item 19)?
- MN Filing 35653-202603-10 has reviewed Item 19 figures for 24 location groups; NexGenEsis Healthcare has reviewed Item 19 figures for 2 location groups. Different location groups are not directly comparable, and revenue is not profit.
Answers restate the reviewed figures above. Not a ranking or recommendation.